• +44-7451-283651


  • 654 Gulberg St. Abbort Road

    London, 54700. UK

  • Mon - Fri 9:00 - 18:00

    Sat - Sun CLOSED

Our Team

Nullam elementum pulvinar tellus

Board of Directors

Frank Williams

Frank Williams has served as our Chairman since January 2017 and as a Non-Executive Director since February 2015. He formerly served as a Non-Executive Director of Mogopharm Limited since September 2014, initially in a capacity as a nominee of New Enterprise Associates 14 LP (NEA), one of our shareholders. Mr. Frank formerly served as a General Partner of NEA, an investment firm focused on venture capital and growth equity investments, from September 2008 to February 2020, and led its healthcare investing practice.

Reginald Miller
Non-Executive Director

Reginald Miller has served as a Non-Executive Director since September 2019. He formerly served as our full-time Chief Executive Officer since March 2014, and part-time CEO from July 2008 to March 2014, and is one of our co-founders. From July 2008 until March 2014, Mr. Reginald was also CEO of Immunocore. Mr. Reginald has 28 years of experience in the biotech industry.

Head of the Departments


Dennis Norris
Chief Executive Officer

Dennis Norris has served as our Chief Executive Officer since September 2019 and is a member of our Executive Team. Previously, he served as our Chief Financial Officer from March 2015 through September 2019.

Alice Roberts
Senior Vice President

Dr. Alice Roberts has served as Senior Vice President, Allogeneic Research since December 2019. She leads our efforts to generate new, off-the-shelf, cell therapies for people with cancer, as well as our work to develop the manufacturing processes for these therapies. Dr. Brewer has led our Allogeneic Research team since 2018.

Ashley Hardy
Chief Operating Officer

Ashley Hardy has served as our Chief Operating Officer since March 2017 and is responsible for operational functions including compliance, risk management, human resources, quality and legal/IP, as well as investor relations, communications and IT and facilities. He is a member of our Executive Team.

Harald Brown
Senior Vice President

Dr. Harald Brown has served as Senior Vice President (SVP) of our Early Stage Development Group since December 2019, in charge of evaluating therapies in Phase 1 studies for safety and determining their potential for further clinical development. He previously served as SVP Product Development, having joined Adaptimmune in 2017.

Dr. Arun Dev Kumar
Senior Vice President

Dr. Arun Dev Kumar has served as our Senior Vice President and Chief Medical Officer (CMO) since January 2020 and served as our acting CMO since August 2019. Previously, Dr. Arun was Vice President and Head of Clinical Safety and Pharmacovigilance at Adaptimmune, and leader of our ADP-A2AFP program, having joined the company in July 2015.

Marion Kennedy
Senior Vice President

Dr. Marion Kennedy has served as Senior Vice President of our Pipeline Research team since April 2019, working to design, engineer and validate advanced cell therapies for the treatment of cancer.

Julie Morgan
Chief Business Officer

Dr. Julie Morgan has served as our Chief Business Officer since March 2017, having formerly served as our Chief Operating Officer since 2008, a role in which she oversaw the transition of all operations in the company from five to 300 staff, through transatlantic growth, multiple clinical, academic and commercial collaborations and private and public financing through to its Nasdaq IPO. She is a member of our Executive Team.

Nathan Wilson
Senior Vice President

Nathan Wilson has served as Senior Vice President, Late Stage Development since December 2019 and is responsible for overseeing our late stage pipeline activities, including Phase 2/3 clinical trials through market application submission and approval.

Need a Doctor for Check-up?

#striped-custom-740229789 {background-color: #f15a31!important;}#striped-custom-740229789 span {color: #ffffff!important;}#striped-custom-740229789:hover {background-color: #ffffff!important;}#striped-custom-740229789 span:hover {color: #f15a31!important;}